Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs

NCT03630692 · clinicaltrials.gov ↗

UNKNOWN

Status

158

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cancer
Stage III Renal Cell Cancer

Interventions

DRUG: observance of oral drug treatment

Sponsor

Institut Cancerologie de l'Ouest

Collaborators

[object Object]
[object Object]